Psychedelic drug developers rally as Trump orders FDA to expedite reviews - Reuters
Reuters
—
Trump signs order on psychedelics
- Compass Pathways CEO on Trump's Order to Expand Psychedelics Research Bloomberg —
- FDA's Makary on Trump EO to Ease Access to Psychedelics Bloomberg —
- Trump’s order on psychedelics could have far-reaching science consequences Scientific American —
- Trump’s call to deregulate psychedelics boosts drugmakers’ shares Financial Times —
- Psychedelic Stocks Soar as Trump Signs Order to Ease Access Bloomberg —